4,174 Shares in The Clorox Company (NYSE:CLX) Acquired by Sciencast Management LP

Sciencast Management LP acquired a new stake in The Clorox Company (NYSE:CLX) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 4,174 shares of the company’s stock, valued at approximately $639,000.

Several other large investors have also recently added to or reduced their stakes in the business. Advisors Asset Management Inc. lifted its position in shares of Clorox by 5.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,096 shares of the company’s stock worth $406,000 after buying an additional 165 shares during the last quarter. Toroso Investments LLC raised its position in shares of Clorox by 96.8% during the 3rd quarter. Toroso Investments LLC now owns 8,839 shares of the company’s stock worth $1,158,000 after purchasing an additional 4,347 shares during the last quarter. Morgan Stanley raised its stake in Clorox by 1.8% in the 3rd quarter. Morgan Stanley now owns 1,738,928 shares of the company’s stock valued at $227,904,000 after purchasing an additional 30,902 shares during the last quarter. Harbour Investments Inc. lifted its stake in shares of Clorox by 3.6% during the 3rd quarter. Harbour Investments Inc. now owns 4,018 shares of the company’s stock worth $527,000 after purchasing an additional 141 shares during the period. Finally, OLD National Bancorp IN lifted its holdings in shares of Clorox by 3.0% during the 3rd quarter. OLD National Bancorp IN now owns 13,444 shares of the company’s stock worth $1,762,000 after acquiring an additional 387 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on CLX shares. Citigroup reduced their target price on shares of Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a report on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Evercore ISI decreased their price objective on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday, May 1st. BNP Paribas assumed coverage on shares of Clorox in a research report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target on the stock. Finally, DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Five research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $144.67.

Clorox Stock Performance

CLX traded up $1.56 during midday trading on Friday, reaching $136.40. The company’s stock had a trading volume of 734,746 shares, compared to its average volume of 1,244,543. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14. The stock has a market cap of $16.94 billion, a P/E ratio of 70.67, a PEG ratio of 2.00 and a beta of 0.39. The company has a fifty day simple moving average of $134.74 and a 200 day simple moving average of $143.19. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the firm posted $1.51 earnings per share. Clorox’s revenue was down 5.3% compared to the same quarter last year. Research analysts expect that The Clorox Company will post 5.91 earnings per share for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.